{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T17:11:05Z","timestamp":1794417065450,"version":"4.9.1"},"reference-count":216,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health Medical Research Council","award":["GNT2007991"],"award-info":[{"award-number":["GNT2007991"]}]},{"name":"National Health Medical Research Council","award":["106035"],"award-info":[{"award-number":["106035"]}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation Vanguard","doi-asserted-by":"publisher","award":["GNT2007991"],"award-info":[{"award-number":["GNT2007991"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation Vanguard","doi-asserted-by":"publisher","award":["106035"],"award-info":[{"award-number":["106035"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Westmead Medical Research Foundation","award":["GNT2007991"],"award-info":[{"award-number":["GNT2007991"]}]},{"name":"Westmead Medical Research Foundation","award":["106035"],"award-info":[{"award-number":["106035"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease (CKD) affects &gt; 10% of the global adult population and significantly increases the risk of cardiovascular disease (CVD), which remains the leading cause of death in this population. The development and progression of CVD\u2014compared to the general population\u2014is premature and accelerated, manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac death. CKD and CV disease combine to cause multimorbid cardiorenal syndrome (CRS) due to contributions from shared risk factors, including systolic hypertension, diabetes mellitus, obesity, and dyslipidemia. Additional neurohormonal activation, innate immunity, and inflammation contribute to progressive cardiac and renal deterioration, reflecting the strong bidirectional interaction between these organ systems. A shared molecular pathophysiology\u2014including inflammation, oxidative stress, senescence, and hemodynamic fluctuations characterise all types of CRS. This review highlights the evolving paradigm and recent advances in our understanding of the molecular biology of CRS, outlining the potential for disease-specific therapies and biomarker disease detection.<\/jats:p>","DOI":"10.3390\/ijms25052658","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T06:50:23Z","timestamp":1708930223000},"page":"2658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5345-8697","authenticated-orcid":false,"given":"Cuicui","family":"Xu","sequence":"first","affiliation":[{"name":"Kidney Injury Group, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tsihlis","sequence":"additional","affiliation":[{"name":"Renal and Transplantation Medicine, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Chau","sequence":"additional","affiliation":[{"name":"Department of Renal Services, Blacktown Hospital, Blacktown, NSW 2148, Australia"},{"name":"Blacktown Clinical School, School of Medicine, Western Sydney University, Sydney, NSW 2148, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-305X","authenticated-orcid":false,"given":"Katie","family":"Trinh","sequence":"additional","affiliation":[{"name":"Kidney Injury Group, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW 2145, Australia"},{"name":"Department of Renal Services, Blacktown Hospital, Blacktown, NSW 2148, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Kidney Injury Group, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW 2145, Australia"},{"name":"Renal and Transplantation Medicine, Westmead Hospital, Westmead, NSW 2145, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Science Rd., Camperdown, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-2366","authenticated-orcid":false,"given":"Sohel M.","family":"Julovi","sequence":"additional","affiliation":[{"name":"Kidney Injury Group, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW 2145, Australia"},{"name":"Faculty of Medicine and Health, The University of Sydney, Science Rd., Camperdown, NSW 2050, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Collaboration","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.semnephrol.2018.08.008","article-title":"Introduction: Cardiovascular Disease in Chronic Kidney Disease","volume":"38","author":"Charytan","year":"2018","journal-title":"Semin. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1523-1755.2002.kid571.x","article-title":"Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study","volume":"62","author":"Henry","year":"2002","journal-title":"Kidney Int."},{"key":"ref_7","unstructured":"Chen, L., Booley, S., Keates, A.K., and Stewart, S. (2017). Mary MacKillop Institute for Health Research, Australian Catholic University."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000313745","article-title":"Cardiorenal syndromes: An executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"Volume 165","author":"Ronco","year":"2010","journal-title":"Cardiorenal Syndromes in Critical Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.117.028814","article-title":"Cardiorenal Syndrome Revisited","volume":"138","author":"Zannad","year":"2018","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e005022","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease","volume":"6","author":"Hung","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","first-page":"338","article-title":"Cases and observations illustrative of renal disease accompanied by the secretion of albuminous urine","volume":"1","author":"Bright","year":"1836","journal-title":"Guys Hosp. Rep."},{"key":"ref_14","unstructured":"National Heart, Lung, and Blood Institute (2024, January 03). NHLBI Working Group: Cardio-Renal Connections in Heart Failure and Cardiovascular Disease, Available online: https:\/\/www.nhlbi.nih.gov\/events\/2004\/cardio-renal-connections-heart-failure-and-cardiovascular-disease."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: Report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: Pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.2004090765","article-title":"High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination","volume":"16","author":"Ohtake","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000441582","article-title":"Ischemic Heart Disease in Patients with End-Stage Kidney Disease","volume":"40","author":"Tanaka","year":"2015","journal-title":"Blood Purif."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ki.2015.117","article-title":"High cardiovascular event rates occur within the first weeks of starting hemodialysis","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11255-020-02683-9","article-title":"Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis","volume":"53","author":"Ng","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2215\/CJN.04470709","article-title":"Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function","volume":"4","author":"Burton","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2215\/CJN.03900808","article-title":"Hemodialysis-induced cardiac injury: Determinants and associated outcomes","volume":"4","author":"Burton","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","first-page":"593","article-title":"Declining prevalence of coronary artery disease in incident dialysis patients over the past two decades","volume":"21","author":"Iwasaki","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.01760506","article-title":"Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients","volume":"2","author":"Gross","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ndt\/15.2.218","article-title":"Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure","volume":"15","author":"Schwarz","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1681\/ASN.V961018","article-title":"Myocyte\/capillary mismatch in the heart of uremic patients","volume":"9","author":"Amann","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2011.07.010","article-title":"Chronic kidney disease and risk for presenting with acute myocardial infarction versus stable exertional angina in adults with coronary heart disease","volume":"58","author":"Go","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2011.69","article-title":"Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis","volume":"80","author":"Russo","year":"2011","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: Different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"856602","DOI":"10.3389\/fcvm.2022.856602","article-title":"Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention","volume":"9","author":"Lai","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.kint.2021.09.005","article-title":"A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function","volume":"101","author":"Heerspink","year":"2022","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: A prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00059-020-05011-0","article-title":"Valvular heart disease in patients with chronic kidney disease","volume":"46","author":"Hoevelmann","year":"2021","journal-title":"Herz"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cjca.2019.05.028","article-title":"Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease","volume":"35","author":"Ternacle","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1523-1755.1999.00391.x","article-title":"Sudden and cardiac death rates in hemodialysis patients","volume":"55","author":"Bleyer","year":"1999","journal-title":"Kidney Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","article-title":"Characteristics of sudden death in hemodialysis patients","volume":"69","author":"Bleyer","year":"2006","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/anec.12119","article-title":"Sudden cardiac arrest in hemodialysis patients with wearable cardioverter defibrillator","volume":"19","author":"Wan","year":"2014","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","article-title":"Cardiac Rhythm Disturbances in Hemodialysis Patients: Early Detection Using an Implantable Loop Recorder and Correlation With Biological and Dialysis Parameters","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: A matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.117.027338","article-title":"Cardiovascular Outcome Trials in Patients With Advanced Kidney Disease: Time for Action","volume":"135","author":"Zannad","year":"2017","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41598-020-58393-w","article-title":"5\/6 nephrectomy induces different renal, cardiac and vascular consequences in 129\/Sv and C57BL\/6JRj mice","volume":"10","author":"Hamzaoui","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/0886022X.2019.1627220","article-title":"An optimized 5\/6 nephrectomy mouse model based on unilateral kidney ligation and its application in renal fibrosis research","volume":"41","author":"Tan","year":"2019","journal-title":"Ren. Fail."},{"key":"ref_51","first-page":"e55825","article-title":"A Mouse 5\/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy","volume":"129","author":"Wang","year":"2017","journal-title":"J. Vis. Exp."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrneph.2014.31","article-title":"Novel targets of antifibrotic and anti-inflammatory treatment in CKD","volume":"10","author":"Decleves","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.6061\/clinics\/2015(04)14","article-title":"Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis","volume":"70","author":"Li","year":"2015","journal-title":"Clinics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.0000013786.80104.D4","article-title":"C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk","volume":"22","author":"Jager","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.0894-0959.2004.17605.x","article-title":"Linking oxidative stress and inflammation in kidney disease: Which is the chicken and which is the egg?","volume":"17","author":"Himmelfarb","year":"2004","journal-title":"Semin. Dial."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2215\/CJN.01290308","article-title":"Epidemiology of acute infections among patients with chronic kidney disease","volume":"3","author":"Dalrymple","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Jazani, N.H., Savoj, J., Lustgarten, M., Lau, W.L., and Vaziri, N.D. (2019). Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases, 7.","DOI":"10.3390\/diseases7010021"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","article-title":"Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease","volume":"65","author":"Eustace","year":"2004","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1172\/JCI83470","article-title":"FGF23 signaling impairs neutrophil recruitment and host defense during CKD","volume":"126","author":"Rossaint","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.ajkd.2004.08.023","article-title":"Resting energy expenditure of chronic kidney disease patients: Influence of renal function and subclinical inflammation","volume":"44","author":"Avesani","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-7075-9-36","article-title":"Exploring metabolic dysfunction in chronic kidney disease","volume":"9","author":"Slee","year":"2012","journal-title":"Nutr. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semnephrol.2011.11.010","article-title":"The role of inflammation in the cardio-renal syndrome: A focus on cytokines and inflammatory mediators","volume":"32","author":"Rosner","year":"2012","journal-title":"Semin. Nephrol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ehf2.12327","article-title":"Systemic inflammation in acute cardiorenal syndrome: An observational pilot study","volume":"5","author":"Linhart","year":"2018","journal-title":"ESC Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of Interleukin-1beta by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1093\/eurheartj\/ehac444","article-title":"Inflammation drives residual risk in chronic kidney disease: A CANTOS substudy","volume":"43","author":"Ridker","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1681\/ASN.2020050595","article-title":"Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1\/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial","volume":"32","author":"Pergola","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and Progression of CKD: The CRIC Study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Isakova","year":"2017","journal-title":"Kidney Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.121.053547","article-title":"Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease","volume":"144","author":"Schunk","year":"2021","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Emerging Risk Factors Collaboration, Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.G., Collins, R., and Danesh, J. (2010). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet, 375, 132\u2013140.","DOI":"10.1016\/S0140-6736(09)61717-7"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2009.954","article-title":"Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease","volume":"302","author":"Elliott","year":"2009","journal-title":"JAMA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41467-022-29650-5","article-title":"Genetic analysis of over half a million people characterises C-reactive protein loci","volume":"13","author":"Said","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar, N., Butterworth, A.S., Freitag, D.F., Gregson, J., Willeit, P., Gorman, D.N., Gao, P., Saleheen, D., and Rendon, A. (2012). Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet, 379, 1205\u20131213.","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/eurheartj\/ehab107","article-title":"Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality","volume":"42","author":"Schunk","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.07000714","article-title":"Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD","volume":"10","author":"Spoto","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Susilo, H., Thaha, M., Pikir, B.S., Alsagaff, M.Y., Suryantoro, S.D., Wungu, C.D.K., Pratama, N.R., Pakpahan, C., and Oceandy, D. (2022). The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease. J. Pers. Med., 12.","DOI":"10.3390\/jpm12071122"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2021.11.020","article-title":"Genetic IL-6 Signaling Modifies Incident Coronary Artery Disease Risk in Chronic Kidney Disease","volume":"79","author":"Yu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"14768","DOI":"10.1038\/s41598-021-94075-x","article-title":"Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis","volume":"11","author":"Rocha","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1523-1755.2005.00403.x","article-title":"Interleukin-1 gene cluster polymorphisms predict risk of ESRD","volume":"68","author":"Wetmore","year":"2005","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/nep.12381","article-title":"Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals","volume":"20","author":"Horibe","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: A collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfv358","article-title":"Innate immunity in CKD-associated vascular diseases","volume":"31","author":"Zewinger","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imr.12534","article-title":"Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases","volume":"277","author":"Man","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","article-title":"Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2","volume":"6","author":"Stenvinkel","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2019.04.025","article-title":"Cardiac arrhythmias after renal I\/R depend on IL-1beta","volume":"131","author":"Alarcon","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1038\/ncomms13344","article-title":"Macrophage-dependent IL-1beta production induces cardiac arrhythmias in diabetic mice","volume":"7","author":"Monnerat","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12174","article-title":"RIP1-driven autoinflammation targets IL-1alpha independently of inflammasomes and RIP3","volume":"498","author":"Lukens","year":"2013","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2013.00391","article-title":"The Interleukin-1alpha Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines","volume":"4","author":"Kim","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ni.3503","article-title":"Interleukin 1alpha and the inflammatory process","volume":"17","author":"Shayakhmetov","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2011.07.037","article-title":"Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha","volume":"44","author":"Afonina","year":"2011","journal-title":"Mol. Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","article-title":"The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1alpha by Thrombin","volume":"50","author":"Burzynski","year":"2019","journal-title":"Immunity"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.ajpc.2020.100130","article-title":"Inflammation and cardiovascular disease: From mechanisms to therapeutics","volume":"4","author":"Alfaddagh","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.stem.2015.04.008","article-title":"Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells","volume":"16","author":"Dutta","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/eurheartj\/eht216","article-title":"Increased risk of coronary heart disease among individuals reporting adverse impact of stress on their health: The Whitehall II prospective cohort study","volume":"34","author":"Nabi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"109595","DOI":"10.1016\/j.celrep.2021.109595","article-title":"Chronic stress primes innate immune responses in mice and humans","volume":"36","author":"Barrett","year":"2021","journal-title":"Cell Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneph.2014.170","article-title":"Dendritic cells and macrophages in the kidney: A spectrum of good and evil","volume":"10","author":"Rogers","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0002-9440(10)64445-8","article-title":"Immunosuppressive treatment protects against angiotensin II-induced renal damage","volume":"161","author":"Muller","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int. J. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Smolgovsky, S., Bayer, A.L., Kaur, K., Sanders, E., Aronovitz, M., Filipp, M.E., Thorp, E.B., Schiattarella, G.G., Hill, J.A., and Blanton, R.M. (2023). Impaired T cell IRE1alpha\/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction. J. Clin. Investig., 133.","DOI":"10.1172\/JCI171874"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2021.04.002","article-title":"Sodium and its manifold impact on our immune system","volume":"42","author":"Jobin","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yang, C.Y., Chen, T.W., Lu, W.L., Liang, S.S., Huang, H.D., Tseng, C.P., and Tarng, D.C. (2021). Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease. Cells, 10.","DOI":"10.3390\/cells10010114"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/eurheartj\/ehaa1050","article-title":"Lipoproteins in chronic kidney disease: From bench to bedside","volume":"42","author":"Speer","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1681\/ASN.2021040503","article-title":"Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury","volume":"32","author":"Schunk","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2013050482","article-title":"HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction","volume":"25","author":"Zewinger","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2215\/CJN.12691117","article-title":"Microbiome and Cardiovascular Disease in CKD","volume":"13","author":"Jovanovich","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","article-title":"Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events","volume":"89","author":"Kim","year":"2016","journal-title":"Kidney Int."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Julovi, S.M., Trinh, K., Robertson, H., Xu, C., Minhas, N., Viswanathan, S., Patrick, E., Horowitz, J.D., Meijles, D.N., and Rogers, N.M. (2024). Thrombospondin-1 drives cardiac remodelling in chronic kidney disease. JACC Basic. Transl. Sci., preprint.","DOI":"10.2139\/ssrn.4661742"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1681\/ASN.2018121251","article-title":"Cellular Senescence in the Kidney","volume":"30","author":"Docherty","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: From mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.kint.2017.12.017","article-title":"Activated renal tubular Wnt\/beta-catenin signaling triggers renal inflammation during overload proteinuria","volume":"93","author":"Wong","year":"2018","journal-title":"Kidney Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2017050574","article-title":"Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells","volume":"29","author":"Luo","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"21643","DOI":"10.1038\/s41598-021-01150-4","article-title":"TGF-beta1 is involved in senescence-related pathways in glomerular endothelial cells via p16 translocation and p21 induction","volume":"11","author":"Ueda","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","year":"2014","journal-title":"Nature"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","article-title":"Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network","volume":"133","author":"Kuilman","year":"2008","journal-title":"Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jacc.2016.02.047","article-title":"Essential Role for Premature Senescence of Myofibroblasts in Myocardial Fibrosis","volume":"67","author":"Meyer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Zhu, F., Li, Y., Zhang, J., Piao, C., Liu, T., Li, H.H., and Du, J. (2013). Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074535"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"F1418","DOI":"10.1152\/ajprenal.00633.2013","article-title":"Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia","volume":"306","author":"Yamada","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10157-022-02216-x","article-title":"Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis","volume":"26","author":"Yamada","year":"2022","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","article-title":"Regulation and Effects of FGF23 in Chronic Kidney Disease","volume":"82","author":"Musgrove","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000454959","article-title":"Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease","volume":"45","author":"Xue","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/eurheartj\/ehq246","article-title":"Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients","volume":"31","author":"Drechsler","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.CIR.0000151611.89232.3B","article-title":"Endothelial cell activation in patients with decompensated heart failure","volume":"111","author":"Colombo","year":"2005","journal-title":"Circulation"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.0000136656.26019.6e","article-title":"Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: Involvement of renin-angiotensin system and oxidative stress","volume":"24","author":"Suda","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","article-title":"Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients","volume":"62","author":"Zoccali","year":"2002","journal-title":"Kidney Int."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"ref_153","first-page":"562","article-title":"Effect of selected drugs on plasma asymmetric dimethylarginine (ADMA) levels","volume":"65","author":"Trocha","year":"2010","journal-title":"Pharmazie"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1177\/1358836X0501000108","article-title":"Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)","volume":"10","author":"Maas","year":"2005","journal-title":"Vasc. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.122.063327","article-title":"Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF","volume":"147","author":"Yeoh","year":"2023","journal-title":"Circulation"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","article-title":"Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials","volume":"5","author":"Packer","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The importance of endothelin-1 for vascular dysfunction in cardiovascular disease","volume":"76","author":"Bohm","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bph.14397","article-title":"Soluble syndecans: Biomarkers for diseases and therapeutic options","volume":"176","author":"Bertrand","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"Starling","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1582-4934.2010.01036.x","article-title":"Statins potently reduce the cytokine-mediated IL-6 release in SMC\/MNC cocultures","volume":"15","author":"Loppnow","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","article-title":"Canagliflozin reduces inflammation and fibrosis biomarkers: A potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease","volume":"62","author":"Heerspink","year":"2019","journal-title":"Diabetologia"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.amjcard.2010.11.005","article-title":"Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region","volume":"107","author":"Gilbert","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","article-title":"Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs","volume":"103","author":"Pasceri","year":"2001","journal-title":"Circulation"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMc2029834","article-title":"Effect of CD47 Blockade on Vascular Inflammation","volume":"384","author":"Jarr","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2215\/CJN.08160813","article-title":"Association of kidney function with changes in the endothelial surface layer","volume":"9","author":"Dane","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1046\/j.1523-1755.2002.00252.x","article-title":"Human uremic plasma increases microvascular permeability to water and proteins in vivo","volume":"61","author":"Harper","year":"2002","journal-title":"Kidney Int."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1681\/ASN.2012030281","article-title":"Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall","volume":"24","author":"Pletinck","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","article-title":"Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion","volume":"101","author":"Vink","year":"2000","journal-title":"Circulation"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s10439-017-1846-0","article-title":"Stenosis Hemodynamics Disrupt the Endothelial Cell Glycocalyx by MMP Activity Creating a Proinflammatory Environment","volume":"45","author":"Cooper","year":"2017","journal-title":"Ann. Biomed. Eng."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11897-017-0320-5","article-title":"Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications","volume":"14","author":"Kim","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"F673","DOI":"10.1152\/ajprenal.00013.2016","article-title":"Markers of endothelial damage in patients with chronic kidney disease on hemodialysis","volume":"312","author":"Carmona","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fphys.2017.00666","article-title":"Microvesicles Derived from Indoxyl Sulfate Treated Endothelial Cells Induce Endothelial Progenitor Cells Dysfunction","volume":"8","author":"Carmona","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.febslet.2013.08.034","article-title":"Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport","volume":"587","author":"Finn","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2009.05.022","article-title":"Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease","volume":"54","author":"Nozaki","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Carracedo, J., Alique, M., Vida, C., Bodega, G., Ceprian, N., Morales, E., Praga, M., de Sequera, P., and Ramirez, R. (2020). Mechanisms of Cardiovascular Disorders in Patients With Chronic Kidney Disease: A Process Related to Accelerated Senescence. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00185"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1681\/ASN.2006080938","article-title":"Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease","volume":"17","author":"Goicoechea","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41581-022-00535-6","article-title":"Kidney and heart failure outcomes associated with SGLT2 inhibitor use","volume":"18","author":"Heerspink","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41581-020-00367-2","article-title":"Incretin drugs in diabetic kidney disease: Biological mechanisms and clinical evidence","volume":"17","author":"Alicic","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/2047487319864671","article-title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","volume":"27","author":"Ballantyne","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/d41573-019-00086-9","article-title":"NLRP3 inhibitors stoke anti-inflammatory ambitions","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrd.2017.267","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"17","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Ge, Y., Huang, M., and Yao, Y.M. (2022). Efferocytosis and Its Role in Inflammatory Disorders. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.839248"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI85782","article-title":"Alternatively activated macrophages determine repair of the infarcted adult murine heart","volume":"126","author":"Shiraishi","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.113.301198","article-title":"Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction","volume":"113","author":"Wan","year":"2013","journal-title":"Circ. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.121.057549","article-title":"Cardiac Resident Macrophage-Derived Legumain Improves Cardiac Repair by Promoting Clearance and Degradation of Apoptotic Cardiomyocytes After Myocardial Infarction","volume":"145","author":"Jia","year":"2022","journal-title":"Circulation"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCULATIONAHA.115.020857","article-title":"Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor","volume":"133","author":"Howangyin","year":"2016","journal-title":"Circulation"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e003126","DOI":"10.1161\/JAHA.115.003126","article-title":"Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure","volume":"5","author":"Salvador","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","article-title":"Resolvin D1 promotes the targeting and clearance of necroptotic cells","volume":"27","author":"Gerlach","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacbts.2017.03.013","article-title":"Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair","volume":"2","author":"Zhang","year":"2017","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0002-9440(10)63874-6","article-title":"Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36","volume":"162","author":"Moodley","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41374-020-0434-3","article-title":"Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis","volume":"100","author":"Julovi","year":"2020","journal-title":"Lab. Investig."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"F607","DOI":"10.1152\/ajprenal.00169.2015","article-title":"G protein alpha(12) (Galpha(12)) is a negative regulator of kidney injury molecule-1-mediated efferocytosis","volume":"310","author":"Ismail","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Huang, W., Wang, B.O., Hou, Y.F., Fu, Y., Cui, S.J., Zhu, J.H., Zhan, X.Y., Li, R.K., Tang, W., and Wu, J.C. (2022). JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism. JCI Insight, 7.","DOI":"10.1172\/jci.insight.158571"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"H1884","DOI":"10.1152\/ajpheart.00967.2011","article-title":"Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: Implications for cardiorenal syndrome","volume":"302","author":"Lekawanvijit","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1172\/JCI45361","article-title":"Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis","volume":"123","author":"Humphreys","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semnephrol.2022.04.006","article-title":"Sex-Based Differences in Risk Factors and Complications of Chronic Kidney Disease","volume":"42","author":"Wyld","year":"2022","journal-title":"Semin. Nephrol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41581-023-00787-w","article-title":"Mechanisms and consequences of sex differences in immune responses","volume":"20","author":"Dunn","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1681\/ASN.2017030295","article-title":"Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis","volume":"28","author":"Veiras","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(18)32995-7","article-title":"Factors affecting sex-related reporting in medical research: A cross-disciplinary bibliometric analysis","volume":"393","author":"Sugimoto","year":"2019","journal-title":"Lancet"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/ckj\/sfad018","article-title":"Women\u2019s representation in clinical trials of patients with chronic kidney disease","volume":"16","author":"Carcel","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjcard.2023.03.034","article-title":"Female Recruitment Into Cardiovascular Disease Trials","volume":"198","author":"Wu","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40119-016-0075-1","article-title":"Does Gender Influence the Cardiovascular Benefits Observed with Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis","volume":"6","author":"Mahmoud","year":"2017","journal-title":"Cardiol. Ther."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/dom.13531","article-title":"Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors","volume":"21","author":"Dave","year":"2019","journal-title":"Diabetes Obes. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/5\/2658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:04:27Z","timestamp":1760105067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/5\/2658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":216,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25052658"],"URL":"https:\/\/doi.org\/10.3390\/ijms25052658","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,24]]}}}